Monophyletic relationships are formed between each protostome and chordate NMDAR subunit, as observed in the full phylogeny. Figure S3: AMPAR subtype only tree indicates a single AMPAR gene in the common bilaterian ancestor. Figure S4: Kainate receptor subunits from chordates and protostomes do not form a strongly supported clade, unlike the strongly support clades observed in the NMDAR and AMPAR subtypes. Figure S5: Hydrophobicity plot of H. sapiens GRIA1 and Aplysia GluR1 TMDs.	"protostome	51	61	Organism/Species"	"chordate	66	74	Organism/Species"	"NMDAR	75	80	Gene/Protein"	"AMPAR	136	141	Gene/Protein"	"AMPAR	179	184	Gene/Protein"	"Kainate receptor	236	252	Gene/Protein"	"chordates	267	276	Organism/Species"	"protostomes	281	292	Organism/Species"	"NMDAR	384	389	Gene/Protein"	"AMPAR	394	399	Gene/Protein"	"GRIA1	455	460	Gene/Protein"	"Aplysia	465	472	Organism/Species"	"GluR1	473	478	Gene/Protein"	"[{""token"": ""protostome"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""chordate"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""NMDAR"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""Kainate receptor"", ""start_span"": 236, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""chordates"", ""start_span"": 267, ""end_span"": 276, ""type"": ""Organism/Species""}, {""token"": ""protostomes"", ""start_span"": 281, ""end_span"": 292, ""type"": ""Organism/Species""}, {""token"": ""NMDAR"", ""start_span"": 384, ""end_span"": 389, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 394, ""end_span"": 399, ""type"": ""Gene/Protein""}, {""token"": ""GRIA1"", ""start_span"": 455, ""end_span"": 460, ""type"": ""Gene/Protein""}, {""token"": ""Aplysia"", ""start_span"": 465, ""end_span"": 472, ""type"": ""Organism/Species""}, {""token"": ""GluR1"", ""start_span"": 473, ""end_span"": 478, ""type"": ""Gene/Protein""}]"
The CP - containing nuclear foci induced by TYLCV partially co - localize with markers of sites of RNA processing. N. benthamiana leaves were co - infiltrated with A. tumefaciens carrying constructs to express CP - GFP ( A) or CP - RFP ( B) together with marker proteins of subnuclear compartments: coilin and fibrillarin fused to RFP ( A ), and ALY4, U3 - 55K, and RNPS1 fused to GFP ( B ).	"CP	4	6	Gene/Protein"	"TYLCV	44	49	Organism/Species"	"CP	210	212	Gene/Protein"	"GFP	215	218	Gene/Protein"	"CP	227	229	Gene/Protein"	"RFP	232	235	Gene/Protein"	"coilin	299	305	Gene/Protein"	"fibrillarin	310	321	Gene/Protein"	"RFP	331	334	Gene/Protein"	"ALY4	346	350	Gene/Protein"	"U3 - 55K	352	360	Gene/Protein"	"RNPS1	366	371	Gene/Protein"	"GFP	381	384	Gene/Protein"	"[{""token"": ""CP"", ""start_span"": 4, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""TYLCV"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 210, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 227, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""RFP"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""coilin"", ""start_span"": 299, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""fibrillarin"", ""start_span"": 310, ""end_span"": 321, ""type"": ""Gene/Protein""}, {""token"": ""RFP"", ""start_span"": 331, ""end_span"": 334, ""type"": ""Gene/Protein""}, {""token"": ""ALY4"", ""start_span"": 346, ""end_span"": 350, ""type"": ""Gene/Protein""}, {""token"": ""U3 - 55K"", ""start_span"": 352, ""end_span"": 360, ""type"": ""Gene/Protein""}, {""token"": ""RNPS1"", ""start_span"": 366, ""end_span"": 371, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 381, ""end_span"": 384, ""type"": ""Gene/Protein""}]"
Primary antibodies used are as follows: rabbit anti - H - ferritin ( 1 ∶ 1000 dilution, Alpha Diagnostics International ), rabbit anti - L - ferritin ( 1 ∶ 1000 dilution, ABCAM ), rabbit anti - flag ( 1 ∶ 1000 dilution, cell signaling ), rabbit anti - Sidt1 ( 1 ∶ 1000 dilution, Santa Cruz ), rabbit anti - β - actin ( 1 ∶ 2000 dilution, Sigma ), rabbit anti - mouse ferroportin ( 1 ∶ 1000 ). Quantification of western blots was performed using Quantity One ( Bio - Rad) according to the manual.	"antibodies	8	18	Gene/Protein"	"rabbit	40	46	Organism/Species"	"H - ferritin	54	66	Gene/Protein"	"rabbit	123	129	Organism/Species"	"L - ferritin	137	149	Gene/Protein"	"rabbit	180	186	Organism/Species"	"rabbit	238	244	Organism/Species"	"Sidt1	252	257	Gene/Protein"	"rabbit	293	299	Organism/Species"	"β - actin	307	316	Gene/Protein"	"rabbit	347	353	Organism/Species"	"mouse	361	366	Organism/Species"	"ferroportin	367	378	Gene/Protein"	"[{""token"": ""antibodies"", ""start_span"": 8, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""H - ferritin"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""L - ferritin"", ""start_span"": 137, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Organism/Species""}, {""token"": ""Sidt1"", ""start_span"": 252, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 293, ""end_span"": 299, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - actin"", ""start_span"": 307, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 347, ""end_span"": 353, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 361, ""end_span"": 366, ""type"": ""Organism/Species""}, {""token"": ""ferroportin"", ""start_span"": 367, ""end_span"": 378, ""type"": ""Gene/Protein""}]"
We have identified that the genes responsible for the innate immune response pathway, e. g ., NFκB, IL - 8, IL - 6, and their negative regulators ( SIGRR, IRAK - M, A20, etc .) are either increased ( NFκB, IL - 8, IL - 6) or decreased ( negative regulators SIGRR, IRAK - M, A20, etc .) developmentally causing an aberrant response to these bacteria [ 8 – 10 ].	"NFκB	94	98	Gene/Protein"	"IL - 8	100	106	Gene/Protein"	"IL - 6	108	114	Gene/Protein"	"SIGRR	148	153	Gene/Protein"	"IRAK - M	155	163	Gene/Protein"	"A20	165	168	Gene/Protein"	"NFκB	200	204	Gene/Protein"	"IL - 8	206	212	Gene/Protein"	"IL - 6	214	220	Gene/Protein"	"SIGRR	257	262	Gene/Protein"	"IRAK - M	264	272	Gene/Protein"	"A20	274	277	Gene/Protein"	"bacteria	340	348	Organism/Species"	"[{""token"": ""NF\u03baB"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""SIGRR"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""IRAK - M"", ""start_span"": 155, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""A20"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NF\u03baB"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 214, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""SIGRR"", ""start_span"": 257, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""IRAK - M"", ""start_span"": 264, ""end_span"": 272, ""type"": ""Gene/Protein""}, {""token"": ""A20"", ""start_span"": 274, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 340, ""end_span"": 348, ""type"": ""Organism/Species""}]"
Using RT - PCR, we detected high levels of murine Miwi2 in undifferentiated cell types, including immunophenotypic hematopoietic stem cells ( HSC; Lin - cKit + Sca + CD150 + CD105 +), multi - potent progenitors ( MPP; Lin − cKit + Sca + CD150 − CD105 −), and granulocyte - macrophage progenitors ( GMP; Lin − cKit + Sca − CD150 − CD16 / 32 +), as compared to more committed cell types, red blood cells ( RBC ), macrophages ( Mac ), neutrophils ( Neutr ), B - cells, and T - cells ( Fig. 1 ).	"Miwi2	50	55	Gene/Protein"	"cKit	153	157	Gene/Protein"	"Sca	160	163	Gene/Protein"	"CD150	166	171	Gene/Protein"	"CD105	174	179	Gene/Protein"	"cKit	224	228	Gene/Protein"	"Sca	231	234	Gene/Protein"	"CD150	237	242	Gene/Protein"	"CD105	245	250	Gene/Protein"	"cKit	309	313	Gene/Protein"	"Sca	316	319	Gene/Protein"	"CD150	322	327	Gene/Protein"	"CD16	330	334	Gene/Protein"	"[{""token"": ""Miwi2"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""cKit"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Sca"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""CD150"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""CD105"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""cKit"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""Sca"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""CD150"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""CD105"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""cKit"", ""start_span"": 309, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""Sca"", ""start_span"": 316, ""end_span"": 319, ""type"": ""Gene/Protein""}, {""token"": ""CD150"", ""start_span"": 322, ""end_span"": 327, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 330, ""end_span"": 334, ""type"": ""Gene/Protein""}]"
Protein interaction - mediated connectivity between Shank3 and upstream regulators of mTORC1. ( A) The diagram shows a summary of protein interaction - mediated connectivity between Shank3 and the upstream regulators of mTORC1 ( tuberous sclerosis 1, TSC1 / TSC2 and Ras homolog enriched in striatum, Rhes ). ( B) The Venn diagram shows the number of interactors shared by Shank3, TSC1, TSC2 and Rhes proteins.	"Shank3	52	58	Gene/Protein"	"mTORC1	86	92	Gene/Protein"	"Shank3	182	188	Gene/Protein"	"mTORC1	220	226	Gene/Protein"	"tuberous sclerosis 1	229	249	Gene/Protein"	"TSC1	251	255	Gene/Protein"	"TSC2	258	262	Gene/Protein"	"Ras homolog enriched in striatum	267	299	Gene/Protein"	"Rhes	301	305	Gene/Protein"	"Shank3	373	379	Gene/Protein"	"TSC1	381	385	Gene/Protein"	"TSC2	387	391	Gene/Protein"	"Rhes	396	400	Gene/Protein"	"[{""token"": ""Shank3"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 220, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""tuberous sclerosis 1"", ""start_span"": 229, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""TSC1"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 258, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""Ras homolog enriched in striatum"", ""start_span"": 267, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 301, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 373, ""end_span"": 379, ""type"": ""Gene/Protein""}, {""token"": ""TSC1"", ""start_span"": 381, ""end_span"": 385, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 387, ""end_span"": 391, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 396, ""end_span"": 400, ""type"": ""Gene/Protein""}]"
This gene family, is known under several pseudonyms, including the CATERPILLER ( CLR ), NACHT, NOD - LRR or NOD - like receptor ( NLR) family and is comprised of two major subfamilies of NOD and NALP molecules, along with 3 divergent members; IPAF, the MHC class II transactivator ( CIITA) and neuronal apoptosis inhibitory protein ( NAIP) [ 1, 2 ].	"CATERPILLER	67	78	Gene/Protein"	"CLR	81	84	Gene/Protein"	"NACHT	88	93	Gene/Protein"	"NOD	95	98	Gene/Protein"	"NOD - like receptor	108	127	Gene/Protein"	"NLR	130	133	Gene/Protein"	"NOD	187	190	Gene/Protein"	"NALP	195	199	Gene/Protein"	"IPAF	243	247	Gene/Protein"	"MHC class II transactivator	253	280	Gene/Protein"	"CIITA	283	288	Gene/Protein"	"neuronal apoptosis inhibitory protein	294	331	Gene/Protein"	"NAIP	334	338	Gene/Protein"	"[{""token"": ""CATERPILLER"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""CLR"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""NACHT"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NOD"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NOD - like receptor"", ""start_span"": 108, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""NLR"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NOD"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""NALP"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""IPAF"", ""start_span"": 243, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II transactivator"", ""start_span"": 253, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 283, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""neuronal apoptosis inhibitory protein"", ""start_span"": 294, ""end_span"": 331, ""type"": ""Gene/Protein""}, {""token"": ""NAIP"", ""start_span"": 334, ""end_span"": 338, ""type"": ""Gene/Protein""}]"
Both NOD4 ( NLR - A4) and NOD5 ( NLR - A5) orthologs in zebrafish have conserved sequences within their LRR domains relative to their human equivalents, although the predicted LRR for zebrafish NLR - A4 is shorter than that of human NOD4, and less conserved relative other human and zebrafish NLR - A orthologs.	"NOD4	5	9	Gene/Protein"	"NLR - A4	12	20	Gene/Protein"	"NOD5	26	30	Gene/Protein"	"NLR - A5	33	41	Gene/Protein"	"zebrafish	56	65	Organism/Species"	"human	134	139	Organism/Species"	"zebrafish	184	193	Organism/Species"	"NLR - A4	194	202	Gene/Protein"	"human	227	232	Organism/Species"	"NOD4	233	237	Gene/Protein"	"human	273	278	Organism/Species"	"zebrafish	283	292	Organism/Species"	"NLR - A	293	300	Gene/Protein"	"[{""token"": ""NOD4"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A4"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""NOD5"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A5"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""zebrafish"", ""start_span"": 56, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Organism/Species""}, {""token"": ""NLR - A4"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Organism/Species""}, {""token"": ""NOD4"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 273, ""end_span"": 278, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 283, ""end_span"": 292, ""type"": ""Organism/Species""}, {""token"": ""NLR - A"", ""start_span"": 293, ""end_span"": 300, ""type"": ""Gene/Protein""}]"
Predicted genes for non - mammalian NLRs were identified in the UNIPROT database and at ENSEMBL [ 33] for chicken Gallus gallus, pipid frog Xenopus tropicalis, Japanese pufferfish Fugu rubripes, green spotted pufferfish Tetraodon nigroviridis and zebrafish Danio rerio, by using the BLAST algorithm to search for sequences with similarity to human NLRs [ 34 ].	"NLRs	36	40	Gene/Protein"	"chicken	106	113	Organism/Species"	"Gallus gallus	114	127	Organism/Species"	"pipid frog	129	139	Organism/Species"	"Xenopus tropicalis	140	158	Organism/Species"	"Japanese pufferfish	160	179	Organism/Species"	"Fugu rubripes	180	193	Organism/Species"	"green spotted pufferfish	195	219	Organism/Species"	"Tetraodon nigroviridis	220	242	Organism/Species"	"zebrafish	247	256	Organism/Species"	"Danio rerio	257	268	Organism/Species"	"human	342	347	Organism/Species"	"NLRs	348	352	Gene/Protein"	"[{""token"": ""NLRs"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""chicken"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""Gallus gallus"", ""start_span"": 114, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""pipid frog"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""Xenopus tropicalis"", ""start_span"": 140, ""end_span"": 158, ""type"": ""Organism/Species""}, {""token"": ""Japanese pufferfish"", ""start_span"": 160, ""end_span"": 179, ""type"": ""Organism/Species""}, {""token"": ""Fugu rubripes"", ""start_span"": 180, ""end_span"": 193, ""type"": ""Organism/Species""}, {""token"": ""green spotted pufferfish"", ""start_span"": 195, ""end_span"": 219, ""type"": ""Organism/Species""}, {""token"": ""Tetraodon nigroviridis"", ""start_span"": 220, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 247, ""end_span"": 256, ""type"": ""Organism/Species""}, {""token"": ""Danio rerio"", ""start_span"": 257, ""end_span"": 268, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 342, ""end_span"": 347, ""type"": ""Organism/Species""}, {""token"": ""NLRs"", ""start_span"": 348, ""end_span"": 352, ""type"": ""Gene/Protein""}]"
Obtained macrophages were analyzed by flow cytometry ( CD14, CD16, CD64, CD86, CD200R and CD163 ), ELISA ( IL - 6, IL - 8, IL - 10, monocyte colony stimulating factor M - CSF) and zymography ( matrix metalloproteinase 9, MMP - 9 ).	"CD14	55	59	Gene/Protein"	"CD16	61	65	Gene/Protein"	"CD64	67	71	Gene/Protein"	"CD86	73	77	Gene/Protein"	"CD200R	79	85	Gene/Protein"	"CD163	90	95	Gene/Protein"	"IL - 6	107	113	Gene/Protein"	"IL - 8	115	121	Gene/Protein"	"IL - 10	123	130	Gene/Protein"	"monocyte colony stimulating factor	132	166	Gene/Protein"	"M - CSF	167	174	Gene/Protein"	"matrix metalloproteinase 9	193	219	Gene/Protein"	"MMP - 9	221	228	Gene/Protein"	"[{""token"": ""CD14"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD64"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CD200R"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""monocyte colony stimulating factor"", ""start_span"": 132, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""matrix metalloproteinase 9"", ""start_span"": 193, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 221, ""end_span"": 228, ""type"": ""Gene/Protein""}]"
As a proof of concept, we showed that the isolated CD14 + cells could be differentiated to M1 ( high CD64, high IL - 6 secretion ), M2a ( high CD200R and CD86, low IL - 6 and high IL - 8 secretion) and M2c macrophages ( high CD163, low IL - 6 and high IL - 10 secretion ), respectively, using IFN - γ, IL - 4 and IL - 10, thus, demonstrating their proven [ 34] ex vivo plasticity ( Figs. 2, 3 and 4 and Additional file 3 ).	"CD14	51	55	Gene/Protein"	"CD64	101	105	Gene/Protein"	"IL - 6	112	118	Gene/Protein"	"CD200R	143	149	Gene/Protein"	"CD86	154	158	Gene/Protein"	"IL - 6	164	170	Gene/Protein"	"IL - 8	180	186	Gene/Protein"	"CD163	225	230	Gene/Protein"	"IL - 6	236	242	Gene/Protein"	"IL - 10	252	259	Gene/Protein"	"IFN - γ	293	300	Gene/Protein"	"IL - 4	302	308	Gene/Protein"	"IL - 10	313	320	Gene/Protein"	"[{""token"": ""CD14"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CD64"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CD200R"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 236, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 252, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 293, ""end_span"": 300, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 302, ""end_span"": 308, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 313, ""end_span"": 320, ""type"": ""Gene/Protein""}]"
Considering M1 differentiation in the presence of IFN - γ, none of the CM affected the expression levels of M1 surface - markers ( Additional file 4) nor the secretion profile ( data not shown ). Fig. 2Flow cytometry analysis of CD14 + cells differentiated for 5 days with or without 50% conditioned media ( CM ). a - e Percentual variation of median fluorescence intensity ( MedFI) of CD14, CD16, CD86, CD200R and CD163 compared to control ( CTR ), n = 5. f Monocyte colony stimulating factor ( M - CSF) protein levels in breast cancer cell line CM ( n = 3 ). g - i Flow cytometry analysis of CD14 + cells differentiated in the presence of IL - 10 for 5 days with or without 50% breast cancer cell line CM.	"IFN - γ	50	57	Gene/Protein"	"CD14	229	233	Gene/Protein"	"CD14	386	390	Gene/Protein"	"CD16	392	396	Gene/Protein"	"CD86	398	402	Gene/Protein"	"CD200R	404	410	Gene/Protein"	"CD163	415	420	Gene/Protein"	"Monocyte colony stimulating factor	459	493	Gene/Protein"	"M - CSF	496	503	Gene/Protein"	"breast cancer	523	536	Disease/Disorder"	"CD14	594	598	Gene/Protein"	"IL - 10	641	648	Gene/Protein"	"breast cancer	680	693	Disease/Disorder"	"[{""token"": ""IFN - \u03b3"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 386, ""end_span"": 390, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 392, ""end_span"": 396, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 398, ""end_span"": 402, ""type"": ""Gene/Protein""}, {""token"": ""CD200R"", ""start_span"": 404, ""end_span"": 410, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 415, ""end_span"": 420, ""type"": ""Gene/Protein""}, {""token"": ""Monocyte colony stimulating factor"", ""start_span"": 459, ""end_span"": 493, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 496, ""end_span"": 503, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 523, ""end_span"": 536, ""type"": ""Disease/Disorder""}, {""token"": ""CD14"", ""start_span"": 594, ""end_span"": 598, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 641, ""end_span"": 648, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 680, ""end_span"": 693, ""type"": ""Disease/Disorder""}]"
Moreover, the Apicomplexa was split into four groups including the most basal cryptosporidean ( e. g. Cryptosporidium ), followed by the coccidians ( e. g. Eimeria, Goussia, Calyptospora and Toxoplasma ), and the sister groups of the haemosporidians ( e. g. Plasmodium) and piroplasmids ( Babesia and Theileria) ( see [ 4 ]).	"Apicomplexa	14	25	Organism/Species"	"cryptosporidean	78	93	Organism/Species"	"Cryptosporidium	102	117	Organism/Species"	"coccidians	137	147	Organism/Species"	"Eimeria	156	163	Organism/Species"	"Goussia	165	172	Organism/Species"	"Calyptospora	174	186	Organism/Species"	"Toxoplasma	191	201	Organism/Species"	"haemosporidians	234	249	Organism/Species"	"Plasmodium	258	268	Organism/Species"	"piroplasmids	274	286	Organism/Species"	"Babesia	289	296	Organism/Species"	"Theileria	301	310	Organism/Species"	"[{""token"": ""Apicomplexa"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""cryptosporidean"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""Cryptosporidium"", ""start_span"": 102, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""coccidians"", ""start_span"": 137, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""Eimeria"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Organism/Species""}, {""token"": ""Goussia"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""Calyptospora"", ""start_span"": 174, ""end_span"": 186, ""type"": ""Organism/Species""}, {""token"": ""Toxoplasma"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Organism/Species""}, {""token"": ""haemosporidians"", ""start_span"": 234, ""end_span"": 249, ""type"": ""Organism/Species""}, {""token"": ""Plasmodium"", ""start_span"": 258, ""end_span"": 268, ""type"": ""Organism/Species""}, {""token"": ""piroplasmids"", ""start_span"": 274, ""end_span"": 286, ""type"": ""Organism/Species""}, {""token"": ""Babesia"", ""start_span"": 289, ""end_span"": 296, ""type"": ""Organism/Species""}, {""token"": ""Theileria"", ""start_span"": 301, ""end_span"": 310, ""type"": ""Organism/Species""}]"
Interestingly, PPARα binding to the Bmal1 promoter was time - of - day dependent ( Fig. 3C ), indicating that the mechanism of regulation by PPARα of the Fgf21 promoter is different from the regulation of the Bmal1 promoter. Fig. 3. Chromatin immunoprecipitation of REV - ERBα, HNF6, PPARα and PER2 on the Fgf21 promoter of liver chromatin. ( A) Binding of REV - ERBα to its own promoter and to the Bmal1 and Fgf21 promoters at Zeitgeber time ( ZT) 10 ( black bars) and ZT22 ( white bars ), respectively.	"PPARα	15	20	Gene/Protein"	"Bmal1	36	41	Gene/Protein"	"PPARα	141	146	Gene/Protein"	"Fgf21	154	159	Gene/Protein"	"Bmal1	209	214	Gene/Protein"	"REV - ERBα	266	276	Gene/Protein"	"HNF6	278	282	Gene/Protein"	"PPARα	284	289	Gene/Protein"	"PER2	294	298	Gene/Protein"	"Fgf21	306	311	Gene/Protein"	"REV - ERBα	357	367	Gene/Protein"	"Bmal1	399	404	Gene/Protein"	"Fgf21	409	414	Gene/Protein"	"[{""token"": ""PPAR\u03b1"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 266, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""HNF6"", ""start_span"": 278, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 284, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""PER2"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 306, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 357, ""end_span"": 367, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 399, ""end_span"": 404, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 409, ""end_span"": 414, ""type"": ""Gene/Protein""}]"
A comparison of patients with paroxysmal ( PH - AF paroxysmal) and chronic ( PH - AF chronic) AF in PH revealed chronic AF to be associate with PH due to pulmonary disease ( PH - AF paroxysmal 0% vs. PH - AF chronic 11. 9 %, p < 0. 05 ).	"PH	43	45	Disease/Disorder"	"AF paroxysmal	48	61	Disease/Disorder"	"PH	77	79	Disease/Disorder"	"AF	82	84	Disease/Disorder"	"AF	94	96	Disease/Disorder"	"PH	100	102	Disease/Disorder"	"chronic AF	112	122	Disease/Disorder"	"PH	144	146	Disease/Disorder"	"pulmonary disease	154	171	Disease/Disorder"	"PH	174	176	Disease/Disorder"	"AF paroxysmal	179	192	Disease/Disorder"	"PH	200	202	Disease/Disorder"	"AF	205	207	Disease/Disorder"	"[{""token"": ""PH"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Disease/Disorder""}, {""token"": ""AF paroxysmal"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 82, ""end_span"": 84, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 94, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 100, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""chronic AF"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Disease/Disorder""}, {""token"": ""pulmonary disease"", ""start_span"": 154, ""end_span"": 171, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 174, ""end_span"": 176, ""type"": ""Disease/Disorder""}, {""token"": ""AF paroxysmal"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 200, ""end_span"": 202, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 205, ""end_span"": 207, ""type"": ""Disease/Disorder""}]"
Moreover, PH due to systolic dysfunction was associated with chronic AF, while diastolic dysfunction was related to paroxysmal AF ( systolic dysfunction: PH - AF paroxysmal 3. 6% vs. PH - AF chronic 21. 4 %, p < 0. 05; diastolic dysfunction: PH - AF paroxysmal 32. 1% vs. PH - AF chronic 19. 0 %, p < 0. 05 ).	"PH	10	12	Disease/Disorder"	"systolic dysfunction	20	40	Disease/Disorder"	"chronic AF	61	71	Disease/Disorder"	"paroxysmal AF	116	129	Disease/Disorder"	"systolic dysfunction	132	152	Disease/Disorder"	"PH	154	156	Disease/Disorder"	"AF paroxysmal	159	172	Disease/Disorder"	"PH	183	185	Disease/Disorder"	"AF	188	190	Disease/Disorder"	"PH	242	244	Disease/Disorder"	"AF paroxysmal	247	260	Disease/Disorder"	"PH	272	274	Disease/Disorder"	"AF	277	279	Disease/Disorder"	"[{""token"": ""PH"", ""start_span"": 10, ""end_span"": 12, ""type"": ""Disease/Disorder""}, {""token"": ""systolic dysfunction"", ""start_span"": 20, ""end_span"": 40, ""type"": ""Disease/Disorder""}, {""token"": ""chronic AF"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Disease/Disorder""}, {""token"": ""paroxysmal AF"", ""start_span"": 116, ""end_span"": 129, ""type"": ""Disease/Disorder""}, {""token"": ""systolic dysfunction"", ""start_span"": 132, ""end_span"": 152, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 154, ""end_span"": 156, ""type"": ""Disease/Disorder""}, {""token"": ""AF paroxysmal"", ""start_span"": 159, ""end_span"": 172, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 183, ""end_span"": 185, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 188, ""end_span"": 190, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 242, ""end_span"": 244, ""type"": ""Disease/Disorder""}, {""token"": ""AF paroxysmal"", ""start_span"": 247, ""end_span"": 260, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 272, ""end_span"": 274, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 277, ""end_span"": 279, ""type"": ""Disease/Disorder""}]"
They modulate channel gating, and can function as CAMs both in the presence and absence of α subunits. 5 They are substrates for secretase cleavage, releasing soluble intracellular domains that may regulate gene expression. 6 The β1 subunit ( gene: SCN1B) participates in trans - homophilic adhesion, resulting in cellular aggregation and cytoskeleton recruitment. 7, 8 β1 also interacts heterophilically with other CAMs, including β2, contactin, neurofascins, NrCAM, N - cadherin9 – 12 and the extracellular matrix protein, tenascin - R. 13 β1 mediates neurite outgrowth by a trans - homophilic adhesion mechanism that requires fyn kinase, contactin and γ - secretase activity. 5, 14, 15 β1 plays a critical role during central nervous system ( CNS) development, regulating electrical excitability, proliferation, fasciculation, pathfinding and migration. 15 – 17	"CAMs	50	54	Gene/Protein"	"secretase	129	138	Gene/Protein"	"SCN1B	249	254	Gene/Protein"	"CAMs	416	420	Gene/Protein"	"contactin	436	445	Gene/Protein"	"neurofascins	447	459	Gene/Protein"	"NrCAM	461	466	Gene/Protein"	"N - cadherin9	468	481	Gene/Protein"	"extracellular matrix protein	495	523	Gene/Protein"	"tenascin - R	525	537	Gene/Protein"	"fyn kinase	629	639	Gene/Protein"	"contactin	641	650	Gene/Protein"	"γ - secretase	655	668	Gene/Protein"	"[{""token"": ""CAMs"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""secretase"", ""start_span"": 129, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""SCN1B"", ""start_span"": 249, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""CAMs"", ""start_span"": 416, ""end_span"": 420, ""type"": ""Gene/Protein""}, {""token"": ""contactin"", ""start_span"": 436, ""end_span"": 445, ""type"": ""Gene/Protein""}, {""token"": ""neurofascins"", ""start_span"": 447, ""end_span"": 459, ""type"": ""Gene/Protein""}, {""token"": ""NrCAM"", ""start_span"": 461, ""end_span"": 466, ""type"": ""Gene/Protein""}, {""token"": ""N - cadherin9"", ""start_span"": 468, ""end_span"": 481, ""type"": ""Gene/Protein""}, {""token"": ""extracellular matrix protein"", ""start_span"": 495, ""end_span"": 523, ""type"": ""Gene/Protein""}, {""token"": ""tenascin - R"", ""start_span"": 525, ""end_span"": 537, ""type"": ""Gene/Protein""}, {""token"": ""fyn kinase"", ""start_span"": 629, ""end_span"": 639, ""type"": ""Gene/Protein""}, {""token"": ""contactin"", ""start_span"": 641, ""end_span"": 650, ""type"": ""Gene/Protein""}, {""token"": ""\u03b3 - secretase"", ""start_span"": 655, ""end_span"": 668, ""type"": ""Gene/Protein""}]"
In contrast, the numbers of CD5 + CD19 +, IL - 10 + CD19 +, CD5 + CD1d + CD19 +, and IL - 10 + CD5 + CD1d + CD19 + B cells per microliter of blood and the serum IL - 10 concentration were significantly lower in HSPN patients.	"CD5	28	31	Gene/Protein"	"CD19	34	38	Gene/Protein"	"IL - 10	42	49	Gene/Protein"	"CD19	52	56	Gene/Protein"	"CD5	60	63	Gene/Protein"	"CD1d	66	70	Gene/Protein"	"CD19	73	77	Gene/Protein"	"IL - 10	85	92	Gene/Protein"	"CD5	95	98	Gene/Protein"	"CD1d	101	105	Gene/Protein"	"CD19	108	112	Gene/Protein"	"IL - 10	161	168	Gene/Protein"	"HSPN	211	215	Disease/Disorder"	"[{""token"": ""CD5"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Disease/Disorder""}]"
( B - F) The numbers of CD38 + CD19 +, CD86 + CD19 +, IL - 10 + CD19 +, CD5 + CD1d + CD19 +, and CD5 + CD1d + IL - 10 + CD19 + B cells of individual patients in the pre - and post - treatment stages.	"CD38	24	28	Gene/Protein"	"CD19	31	35	Gene/Protein"	"CD86	39	43	Gene/Protein"	"CD19	46	50	Gene/Protein"	"IL - 10	54	61	Gene/Protein"	"CD19	64	68	Gene/Protein"	"CD5	72	75	Gene/Protein"	"CD1d	78	82	Gene/Protein"	"CD19	85	89	Gene/Protein"	"CD5	97	100	Gene/Protein"	"CD1d	103	107	Gene/Protein"	"IL - 10	110	117	Gene/Protein"	"CD19	120	124	Gene/Protein"	"[{""token"": ""CD38"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}]"
Upon binding to LPS, the LPS ‐ MD2 ‐ TLR4 complex forms and activates downstream pro ‐ inflammatory signalling cascades, leading to the activation of NF ‐ κB, activating protein ‐ 1 ( AP ‐ 1) and mitogen ‐ activated protein kinase ( MAPK) 23, and then induces cytokines such as tumour necrosis factor ‐ α ( TNF ‐ α ), interleukin ‐ ( IL) 1β, IL ‐ 6 and interferon ‐ γ ( IFN ‐ γ) 15, 24, 25, 26, 27.	"MD2	31	34	Gene/Protein"	"TLR4	37	41	Gene/Protein"	"NF ‐ κB	150	157	Gene/Protein"	"activating protein ‐ 1	159	181	Gene/Protein"	"AP ‐ 1	184	190	Gene/Protein"	"mitogen ‐ activated protein kinase	196	230	Gene/Protein"	"MAPK	233	237	Gene/Protein"	"cytokines	260	269	Gene/Protein"	"tumour necrosis factor ‐ α	278	304	Gene/Protein"	"TNF ‐ α	307	314	Gene/Protein"	"IL ‐ 6	342	348	Gene/Protein"	"interferon ‐ γ	353	367	Gene/Protein"	"IFN ‐ γ	370	377	Gene/Protein"	"[{""token"": ""MD2"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NF \u2010 \u03baB"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""activating protein \u2010 1"", ""start_span"": 159, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""AP \u2010 1"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""mitogen \u2010 activated protein kinase"", ""start_span"": 196, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 260, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""tumour necrosis factor \u2010 \u03b1"", ""start_span"": 278, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""TNF \u2010 \u03b1"", ""start_span"": 307, ""end_span"": 314, ""type"": ""Gene/Protein""}, {""token"": ""IL \u2010 6"", ""start_span"": 342, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""interferon \u2010 \u03b3"", ""start_span"": 353, ""end_span"": 367, ""type"": ""Gene/Protein""}, {""token"": ""IFN \u2010 \u03b3"", ""start_span"": 370, ""end_span"": 377, ""type"": ""Gene/Protein""}]"
No significant differences between old and young D2G retina were shown for the following cytokines: FGF - 2 ( t ( 9) = − 2. 173, p = 0. 058 ), IL - 10 ( t ( 6) = 0. 389, p = 0. 711 ), IL - 5 ( t ( 10) = − 0. 166, p = 0. 871 ), VEGF ( t ( 10) = 0. 339, p = 0. 742 ), IL - 12 ( t ( 10) = 1. 000, p = 0. 341 ), IL - 17 ( t ( 10) = 1. 213, p = 0. 92 ), IL - 1α ( t ( 10) = 0. 552, p = 0. 593 ), TNF - α ( t ( 10) = − 0. 411, p = 0. 690 ), IFN - γ ( t ( 9) = − 0. 333, p = 0. 747 ), MIG ( t ( 10) = − 0. 385, p = 0. 708 ), MIP - 1α ( t ( 10) = 1. 206, p = 0. 255 ), and KC ( t ( 10) = − 0. 957, p = 0. 361) ( data not shown ).	"cytokines	89	98	Gene/Protein"	"FGF - 2	100	107	Gene/Protein"	"IL - 10	143	150	Gene/Protein"	"IL - 5	184	190	Gene/Protein"	"VEGF	227	231	Gene/Protein"	"IL - 12	266	273	Gene/Protein"	"IL - 17	308	315	Gene/Protein"	"IL - 1α	349	356	Gene/Protein"	"TNF - α	391	398	Gene/Protein"	"IFN - γ	435	442	Gene/Protein"	"MIG	478	481	Gene/Protein"	"MIP - 1α	518	526	Gene/Protein"	"KC	565	567	Gene/Protein"	"[{""token"": ""cytokines"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""FGF - 2"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""VEGF"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 266, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 308, ""end_span"": 315, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b1"", ""start_span"": 349, ""end_span"": 356, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 391, ""end_span"": 398, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 435, ""end_span"": 442, ""type"": ""Gene/Protein""}, {""token"": ""MIG"", ""start_span"": 478, ""end_span"": 481, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1\u03b1"", ""start_span"": 518, ""end_span"": 526, ""type"": ""Gene/Protein""}, {""token"": ""KC"", ""start_span"": 565, ""end_span"": 567, ""type"": ""Gene/Protein""}]"
H9c2 rat cardiomyocytes were treated with angiotensin II ( AngII) for 24 hrs in the presence or absence of metformin ( AMPK agonist ), losartan [ AngII type 1 receptor ( AT1R) blocker ], Nω - nitro - L - arginine methyl ester ( L - NAME, pan - NOS inhibitor ), splitomicin ( SIRT1 inhibitor) or pifithrin - α ( p53 inhibitor ).	"rat	5	8	Organism/Species"	"angiotensin II	42	56	Gene/Protein"	"AngII	59	64	Gene/Protein"	"metformin	107	116	Chemical/Drug"	"AMPK	119	123	Gene/Protein"	"losartan	135	143	Chemical/Drug"	"AngII type 1 receptor	146	167	Gene/Protein"	"AT1R	170	174	Gene/Protein"	"NOS	244	247	Gene/Protein"	"splitomicin	261	272	Chemical/Drug"	"SIRT1	275	280	Gene/Protein"	"pifithrin - α	295	308	Chemical/Drug"	"p53	311	314	Gene/Protein"	"[{""token"": ""rat"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Organism/Species""}, {""token"": ""angiotensin II"", ""start_span"": 42, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""metformin"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""AMPK"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""losartan"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""AngII type 1 receptor"", ""start_span"": 146, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""AT1R"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""NOS"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""splitomicin"", ""start_span"": 261, ""end_span"": 272, ""type"": ""Chemical/Drug""}, {""token"": ""SIRT1"", ""start_span"": 275, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""pifithrin - \u03b1"", ""start_span"": 295, ""end_span"": 308, ""type"": ""Chemical/Drug""}, {""token"": ""p53"", ""start_span"": 311, ""end_span"": 314, ""type"": ""Gene/Protein""}]"
The following independent variables were used in the multivariate regression analyses: Maternal pre - pregnancy BMI, age, systolic BP ( SysBP ), diastolic BP ( DiaBP ), and plasma BET - 1, ET - 1, ET - 2, ET - 3, 8 - iso - PGF - 2α ( ISOP ), CRP, ICAM - 1, VCAM - 1, MMP - 1, MMP - 2, MMP - 7, MMP - 9, MMP - 10 and VEGF - A.	"BET - 1	180	187	Gene/Protein"	"ET - 1	189	195	Gene/Protein"	"ET - 2	197	203	Gene/Protein"	"ET - 3	205	211	Gene/Protein"	"CRP	242	245	Gene/Protein"	"ICAM - 1	247	255	Gene/Protein"	"VCAM - 1	257	265	Gene/Protein"	"MMP - 1	267	274	Gene/Protein"	"MMP - 2	276	283	Gene/Protein"	"MMP - 7	285	292	Gene/Protein"	"MMP - 9	294	301	Gene/Protein"	"MMP - 10	303	311	Gene/Protein"	"VEGF - A	316	324	Gene/Protein"	"[{""token"": ""BET - 1"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""ET - 1"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""ET - 2"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""ET - 3"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 242, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 257, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 1"", ""start_span"": 267, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 2"", ""start_span"": 276, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 7"", ""start_span"": 285, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 294, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 10"", ""start_span"": 303, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""VEGF - A"", ""start_span"": 316, ""end_span"": 324, ""type"": ""Gene/Protein""}]"
The overall landscape revealed the presence of thirteen genes located at the intersection of both networks: CD9, EFNA5, FRY, IGFBP7, LARP7, MAML2, MYH10, PDGFRA, PTK2, PTPN18, SLC11A2, SP3 and TMEM158.	"CD9	108	111	Gene/Protein"	"EFNA5	113	118	Gene/Protein"	"FRY	120	123	Gene/Protein"	"IGFBP7	125	131	Gene/Protein"	"LARP7	133	138	Gene/Protein"	"MAML2	140	145	Gene/Protein"	"MYH10	147	152	Gene/Protein"	"PDGFRA	154	160	Gene/Protein"	"PTK2	162	166	Gene/Protein"	"PTPN18	168	174	Gene/Protein"	"SLC11A2	176	183	Gene/Protein"	"SP3	185	188	Gene/Protein"	"TMEM158	193	200	Gene/Protein"	"[{""token"": ""CD9"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""EFNA5"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""FRY"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""IGFBP7"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""LARP7"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""MAML2"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""MYH10"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""PDGFRA"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""PTK2"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""PTPN18"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""SLC11A2"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""SP3"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""TMEM158"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}]"
( a) ( I) The representative IHC staining of Transforming growth factor ( TGFβ1) in HCC tissues; ( II) The representative IHC staining of TGFβ1 in adjacent liver tissues; ( III) The negative staining of TGFβ1 in HCC tissues; ( b) The western immunoblotting results of TGFβ1 in 3 pairs of representative HCC tissues ( T) and adjacent liver tissues ( N ); ( c) The IHC scores of TGFβ1 in HCC tissues were significantly higher than one in adjacent liver tissues ( p < 0. 001 ); ( d) The Spearmen rank test showed that there was positive correlation between TGFβ1 and MRC2 expression in HCC tissues ( r = 0. 347; p < 0. 001 ).	"Transforming growth factor	45	71	Gene/Protein"	"TGFβ1	74	79	Gene/Protein"	"HCC	84	87	Disease/Disorder"	"TGFβ1	138	143	Gene/Protein"	"TGFβ1	203	208	Gene/Protein"	"HCC	212	215	Disease/Disorder"	"TGFβ1	268	273	Gene/Protein"	"HCC	303	306	Disease/Disorder"	"TGFβ1	377	382	Gene/Protein"	"HCC	386	389	Disease/Disorder"	"TGFβ1	554	559	Gene/Protein"	"MRC2	564	568	Gene/Protein"	"HCC	583	586	Disease/Disorder"	"[{""token"": ""Transforming growth factor"", ""start_span"": 45, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b21"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""TGF\u03b21"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b21"", ""start_span"": 203, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Disease/Disorder""}, {""token"": ""TGF\u03b21"", ""start_span"": 268, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 303, ""end_span"": 306, ""type"": ""Disease/Disorder""}, {""token"": ""TGF\u03b21"", ""start_span"": 377, ""end_span"": 382, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 386, ""end_span"": 389, ""type"": ""Disease/Disorder""}, {""token"": ""TGF\u03b21"", ""start_span"": 554, ""end_span"": 559, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 564, ""end_span"": 568, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 583, ""end_span"": 586, ""type"": ""Disease/Disorder""}]"
Commercially available primary antibodies were as follows: rabbit anti - PFN1 ( Cell Signaling, # 3237 ), mouse anti - Myc tag ( Santa Cruz, sc - 40 ), rabbit anti - actin ( Santa Cruz, sc - 1616 - R ), rabbit anti - PP1Cα ( Cell Signaling, # 2582 ), rabbit anti - PP2ACα ( Cell Signaling, # 2038 ), mouse anti - HA tag ( Covance, MMS - 101P ).	"antibodies	31	41	Gene/Protein"	"rabbit	59	65	Organism/Species"	"PFN1	73	77	Gene/Protein"	"mouse	106	111	Organism/Species"	"Myc	119	122	Gene/Protein"	"rabbit	152	158	Organism/Species"	"actin	166	171	Gene/Protein"	"rabbit	203	209	Organism/Species"	"PP1Cα	217	222	Gene/Protein"	"rabbit	251	257	Organism/Species"	"PP2ACα	265	271	Gene/Protein"	"mouse	300	305	Organism/Species"	"HA	313	315	Gene/Protein"	"[{""token"": ""antibodies"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""PFN1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""Myc"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Organism/Species""}, {""token"": ""actin"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Organism/Species""}, {""token"": ""PP1C\u03b1"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 251, ""end_span"": 257, ""type"": ""Organism/Species""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 265, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 300, ""end_span"": 305, ""type"": ""Organism/Species""}, {""token"": ""HA"", ""start_span"": 313, ""end_span"": 315, ""type"": ""Gene/Protein""}]"
Notably, in a null Rad54 background deletion of one Parp - 1 allele caused significantly lower radiation - induced MB tumorigenesis compared with Parp - 1 wt mice [ Rad54 -/-/ Parp - 1 +/-/ Ptc1 +/- ( 56 %) vs Rad54 -/-/ Ptc1 +/- mice ( 84 %), P = 0. 0439] ( Figure 1E and 1F ), suggesting a lethal haploinsufficient interaction between Rad54 and Parp - 1 in the context of radiation oncogenesis.	"Rad54	19	24	Gene/Protein"	"Parp - 1	52	60	Gene/Protein"	"MB	115	117	Disease/Disorder"	"Parp - 1	146	154	Gene/Protein"	"mice	158	162	Organism/Species"	"Rad54	165	170	Gene/Protein"	"Parp - 1	176	184	Gene/Protein"	"Ptc1	190	194	Gene/Protein"	"Rad54	210	215	Gene/Protein"	"Ptc1	221	225	Gene/Protein"	"mice	230	234	Organism/Species"	"Rad54	337	342	Gene/Protein"	"Parp - 1	347	355	Gene/Protein"	"[{""token"": ""Rad54"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""MB"", ""start_span"": 115, ""end_span"": 117, ""type"": ""Disease/Disorder""}, {""token"": ""Parp - 1"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Organism/Species""}, {""token"": ""Rad54"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 221, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Organism/Species""}, {""token"": ""Rad54"", ""start_span"": 337, ""end_span"": 342, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 347, ""end_span"": 355, ""type"": ""Gene/Protein""}]"
We carried out this analysis in the P1 cerebellum of Ptc1 +/- mice with single or combined inactivation of Rad54 and / or Parp - 1 ( Rad54 -/-/ Ptc1 +/-, Parp - 1 -/-/ Ptc1 +/- and Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/-) and results were compared with those from Ptc1 +/- mice using a pathway - based PCR expression array.	"Ptc1	53	57	Gene/Protein"	"mice	62	66	Organism/Species"	"Rad54	107	112	Gene/Protein"	"Parp - 1	122	130	Gene/Protein"	"Rad54	133	138	Gene/Protein"	"Ptc1	144	148	Gene/Protein"	"Parp - 1	154	162	Gene/Protein"	"Ptc1	168	172	Gene/Protein"	"Rad54	181	186	Gene/Protein"	"Parp - 1	192	200	Gene/Protein"	"Ptc1	206	210	Gene/Protein"	"Ptc1	258	262	Gene/Protein"	"mice	267	271	Organism/Species"	"[{""token"": ""Ptc1"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""Rad54"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 192, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 258, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 267, ""end_span"": 271, ""type"": ""Organism/Species""}]"
γ - H2AX and cleaved - caspase - 3 quantification: Three to 5 sections from EGL of Ptc1 +/-, Rad54 -/-/ Ptc1 +/-, Parp - 1 -/-/ Ptc1 +/- and Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- mice were immunostained for γ - H2AX or cleaved caspase - 3. expression levels were evaluated counting stained positive cells / EGL area ( mm2 ).	"H2AX	4	8	Gene/Protein"	"caspase - 3	23	34	Gene/Protein"	"Ptc1	83	87	Gene/Protein"	"Rad54	93	98	Gene/Protein"	"Ptc1	104	108	Gene/Protein"	"Parp - 1	114	122	Gene/Protein"	"Ptc1	128	132	Gene/Protein"	"Rad54	141	146	Gene/Protein"	"Parp - 1	152	160	Gene/Protein"	"Ptc1	166	170	Gene/Protein"	"mice	175	179	Organism/Species"	"H2AX	207	211	Gene/Protein"	"caspase - 3	223	234	Gene/Protein"	"[{""token"": ""H2AX"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""caspase - 3"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Organism/Species""}, {""token"": ""H2AX"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""caspase - 3"", ""start_span"": 223, ""end_span"": 234, ""type"": ""Gene/Protein""}]"
It is relevant that the majority of the genes listed in Table 3 are involved in transcriptional regulation ( GMPS, DCPS, ELL, LPP, AF10, CREBBP, EP300, AF4 ), proliferation ( GAS7) or metabolism ( CBL, GPHN and ACACA, the latter being the rate limiting enzyme for conversion of acetyl - coA into cholesterol ).	"GMPS	109	113	Gene/Protein"	"DCPS	115	119	Gene/Protein"	"ELL	121	124	Gene/Protein"	"LPP	126	129	Gene/Protein"	"AF10	131	135	Gene/Protein"	"CREBBP	137	143	Gene/Protein"	"EP300	145	150	Gene/Protein"	"AF4	152	155	Gene/Protein"	"GAS7	175	179	Gene/Protein"	"CBL	197	200	Gene/Protein"	"GPHN	202	206	Gene/Protein"	"ACACA	211	216	Gene/Protein"	"cholesterol	296	307	Chemical/Drug"	"[{""token"": ""GMPS"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""DCPS"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""ELL"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""LPP"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""AF10"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""CREBBP"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""EP300"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""AF4"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""GAS7"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""CBL"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""GPHN"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""ACACA"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 296, ""end_span"": 307, ""type"": ""Chemical/Drug""}]"
To test whether patients with HBV - HCV co - infection have a lower level of HCV core Ag compared to patients with HCV mono - infection, we measured HCV core Ag levels in the 107 HBV - HCV patients and in 107 age - and gender - matched patients with HCV mono - infection.	"HBV	30	33	Organism/Species"	"HCV	36	39	Organism/Species"	"co - infection	40	54	Disease/Disorder"	"HCV	77	80	Organism/Species"	"core Ag	81	88	Gene/Protein"	"HCV	115	118	Organism/Species"	"infection	126	135	Disease/Disorder"	"HCV	149	152	Organism/Species"	"core Ag	153	160	Gene/Protein"	"HBV	179	182	Organism/Species"	"HCV	185	188	Organism/Species"	"HCV	250	253	Organism/Species"	"infection	261	270	Disease/Disorder"	"[{""token"": ""HBV"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 40, ""end_span"": 54, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""core Ag"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""HCV"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""core Ag"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""HBV"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 250, ""end_span"": 253, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 261, ""end_span"": 270, ""type"": ""Disease/Disorder""}]"
Querying major databases and unfinished genomes with the full - length amino acid sequences from the four human bestrophin paralogues identified 173 homologous proteins in vertebrates ( mammals, birds, amphibians and fishes ), urochordates ( sea squirt ), and invertebrates ( insects, nematodes) ( see Additional file 1 ).	"amino acid	71	81	Chemical/Drug"	"human	106	111	Organism/Species"	"bestrophin	112	122	Gene/Protein"	"vertebrates	172	183	Organism/Species"	"mammals	186	193	Organism/Species"	"birds	195	200	Organism/Species"	"amphibians	202	212	Organism/Species"	"fishes	217	223	Organism/Species"	"urochordates	227	239	Organism/Species"	"sea squirt	242	252	Organism/Species"	"invertebrates	260	273	Organism/Species"	"insects	276	283	Organism/Species"	"nematodes	285	294	Organism/Species"	"[{""token"": ""amino acid"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""human"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""bestrophin"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""vertebrates"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 186, ""end_span"": 193, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 195, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""amphibians"", ""start_span"": 202, ""end_span"": 212, ""type"": ""Organism/Species""}, {""token"": ""fishes"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Organism/Species""}, {""token"": ""urochordates"", ""start_span"": 227, ""end_span"": 239, ""type"": ""Organism/Species""}, {""token"": ""sea squirt"", ""start_span"": 242, ""end_span"": 252, ""type"": ""Organism/Species""}, {""token"": ""invertebrates"", ""start_span"": 260, ""end_span"": 273, ""type"": ""Organism/Species""}, {""token"": ""insects"", ""start_span"": 276, ""end_span"": 283, ""type"": ""Organism/Species""}, {""token"": ""nematodes"", ""start_span"": 285, ""end_span"": 294, ""type"": ""Organism/Species""}]"
Eventually, erythrocytes carried in the bloodstream pass through the spleen and liver where macrophages take up the immune complexes [ 3 ], [ 4 ]. Human immunodeficiency virus type 1 ( HIV) particles are known to be capable of binding to erythrocytes in HIV - negative individuals in vitro by at least three mechanisms: 1) binding of immune complexes through the CR1 receptor, 2) binding of HIV to CR1 by complement proteins but in absence of antibodies, and 3) direct binding of HIV to Duffy antigen receptor for chemokines ( CD55 or DARC) present on erythrocytes [ 5 ]–[ 10 ].	"Human immunodeficiency virus type 1	147	182	Organism/Species"	"HIV	185	188	Organism/Species"	"HIV	254	257	Organism/Species"	"CR1 receptor	363	375	Gene/Protein"	"HIV	391	394	Organism/Species"	"CR1	398	401	Gene/Protein"	"complement proteins	405	424	Gene/Protein"	"antibodies	443	453	Gene/Protein"	"HIV	480	483	Organism/Species"	"Duffy antigen receptor	487	509	Gene/Protein"	"chemokines	514	524	Gene/Protein"	"CD55	527	531	Gene/Protein"	"DARC	535	539	Gene/Protein"	"[{""token"": ""Human immunodeficiency virus type 1"", ""start_span"": 147, ""end_span"": 182, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 254, ""end_span"": 257, ""type"": ""Organism/Species""}, {""token"": ""CR1 receptor"", ""start_span"": 363, ""end_span"": 375, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 391, ""end_span"": 394, ""type"": ""Organism/Species""}, {""token"": ""CR1"", ""start_span"": 398, ""end_span"": 401, ""type"": ""Gene/Protein""}, {""token"": ""complement proteins"", ""start_span"": 405, ""end_span"": 424, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 443, ""end_span"": 453, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 480, ""end_span"": 483, ""type"": ""Organism/Species""}, {""token"": ""Duffy antigen receptor"", ""start_span"": 487, ""end_span"": 509, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 514, ""end_span"": 524, ""type"": ""Gene/Protein""}, {""token"": ""CD55"", ""start_span"": 527, ""end_span"": 531, ""type"": ""Gene/Protein""}, {""token"": ""DARC"", ""start_span"": 535, ""end_span"": 539, ""type"": ""Gene/Protein""}]"
IgGs anti - HIV antibodies most frequently associated to erythrocytes were anti - gp160 in 84. 5% ( 49 / 58 ), anti - p24 in 63. 8% ( 37 / 58 ), anti - p34 in 39. 6% ( 23 / 58 ), anti - p68 in 34. 5% ( 20 / 58 ), anti - gp41 in 25. 8% ( 15 / 58 ), anti - p55 in 22. 4% ( 13 / 58 ), anti - gp120 in 18. 9% ( 11 / 58 ), anti - p52 in 13. 8% ( 8 / 58 ), anti - p40 in 6. 9% ( 4 / 58) and anti - p18 in 1. 7% ( 1 / 58) ( Table S1 ).	"IgGs	0	4	Gene/Protein"	"HIV	12	15	Organism/Species"	"antibodies	16	26	Gene/Protein"	"gp160	82	87	Gene/Protein"	"p24	118	121	Gene/Protein"	"p34	152	155	Gene/Protein"	"p68	186	189	Gene/Protein"	"gp41	220	224	Gene/Protein"	"p55	255	258	Gene/Protein"	"gp120	289	294	Gene/Protein"	"p52	325	328	Gene/Protein"	"p40	358	361	Gene/Protein"	"p18	392	395	Gene/Protein"	"[{""token"": ""IgGs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 16, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""p24"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""p34"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""p68"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""gp41"", ""start_span"": 220, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 255, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 289, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 325, ""end_span"": 328, ""type"": ""Gene/Protein""}, {""token"": ""p40"", ""start_span"": 358, ""end_span"": 361, ""type"": ""Gene/Protein""}, {""token"": ""p18"", ""start_span"": 392, ""end_span"": 395, ""type"": ""Gene/Protein""}]"
Plasma dilutions from 14 HIV - positives individuals ( Ig) ( as a source of HIV - specific antibodies) were incubated with CXCR4 - tropic strain of HIV IIIB ( HIV) in presence of: normal human serum as source of complement ( C) ( HIV + Ig + C) or inactivated normal human serum ( Ci) ( HIV + Ig + Ci ).	"HIV	25	28	Organism/Species"	"Ig	55	57	Gene/Protein"	"HIV	76	79	Organism/Species"	"antibodies	91	101	Gene/Protein"	"CXCR4	123	128	Gene/Protein"	"HIV IIIB	148	156	Organism/Species"	"HIV	159	162	Organism/Species"	"human	187	192	Organism/Species"	"HIV	230	233	Organism/Species"	"Ig	236	238	Gene/Protein"	"human	266	271	Organism/Species"	"HIV	286	289	Organism/Species"	"Ig	292	294	Gene/Protein"	"[{""token"": ""HIV"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""Ig"", ""start_span"": 55, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""CXCR4"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""HIV IIIB"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 230, ""end_span"": 233, ""type"": ""Organism/Species""}, {""token"": ""Ig"", ""start_span"": 236, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 266, ""end_span"": 271, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 286, ""end_span"": 289, ""type"": ""Organism/Species""}, {""token"": ""Ig"", ""start_span"": 292, ""end_span"": 294, ""type"": ""Gene/Protein""}]"
Anti - α1 - adrenergic receptor antibody ( ab137123 ), anti - rabbit immunoglobulin G ( IgG) horseradish peroxidase - conjugated secondary antibody ( ab97051 ), and anti - mouse IgG horseradish peroxidase - conjugated secondary antibody ( ab79023) were obtained from Abcam ( Cambridge, MA, USA ).	"α1 - adrenergic receptor	7	31	Gene/Protein"	"antibody	32	40	Gene/Protein"	"rabbit	62	68	Organism/Species"	"immunoglobulin G	69	85	Gene/Protein"	"IgG	88	91	Gene/Protein"	"horseradish	93	104	Organism/Species"	"peroxidase	105	115	Gene/Protein"	"antibody	139	147	Gene/Protein"	"mouse	172	177	Organism/Species"	"IgG	178	181	Gene/Protein"	"horseradish	182	193	Organism/Species"	"peroxidase	194	204	Gene/Protein"	"antibody	228	236	Gene/Protein"	"[{""token"": ""\u03b11 - adrenergic receptor"", ""start_span"": 7, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""immunoglobulin G"", ""start_span"": 69, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""horseradish"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""horseradish"", ""start_span"": 182, ""end_span"": 193, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 228, ""end_span"": 236, ""type"": ""Gene/Protein""}]"
Further, low micromolar 4 - HNE delays the differentiation marker expression: the functionally important membrane receptors for transferrin ( TfR1, CD71 ), stem cell factor c - kit ( CD117 ), interleukin - 3 ( CD123 ), and erythropoietin ( EpoR) as well as the stem cell marker CD34, and the RBC markers glycophorin A and hemoglobin.	"membrane receptors	105	123	Gene/Protein"	"transferrin	128	139	Gene/Protein"	"TfR1	142	146	Gene/Protein"	"CD71	148	152	Gene/Protein"	"stem cell factor c - kit	156	180	Gene/Protein"	"CD117	183	188	Gene/Protein"	"interleukin - 3	192	207	Gene/Protein"	"CD123	210	215	Gene/Protein"	"erythropoietin	223	237	Gene/Protein"	"EpoR	240	244	Gene/Protein"	"CD34	278	282	Gene/Protein"	"glycophorin A	304	317	Gene/Protein"	"hemoglobin	322	332	Gene/Protein"	"[{""token"": ""membrane receptors"", ""start_span"": 105, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""transferrin"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""TfR1"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""CD71"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""stem cell factor c - kit"", ""start_span"": 156, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""CD117"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 3"", ""start_span"": 192, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""CD123"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 223, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""EpoR"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 278, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""glycophorin A"", ""start_span"": 304, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""hemoglobin"", ""start_span"": 322, ""end_span"": 332, ""type"": ""Gene/Protein""}]"
